Market News How it works Learn FAQ
| AXG 0.0415 -22.86% | XXII 0.1009 14.14% | NEXR 0.6596 47.27% | DVLT 0.0786 -40.81% | SOFI 16.555 14.49% | WFF 0.0629 -29.96% | SHFS 0.0897 -4.57% | SOXL 98.06 8.35% | SNTI 0.1742 -0.51% | EWZ 34.72 1.68% | NVD 3.935 -1.38% | INTC 93.18 3.00% | GPUS 0.2072 16.08% | RCT 0.0625 -24.43% | NU 12.4195 -1.35% | SPCX 149.67 1.89% | SOXS 44.075 -8.14% | JBLU 2.8531 20.38% | NVDA 217.74 0.81% | BBD 2.9602 1.20% | SCHP 25.635 -0.02% | MEGL 0.3749 -47.64% | TQQQ 70.745 3.38% | BITO 10.7201 0.61% | TSLL 11.5099 6.97% | CRWV 58.35 5.73% | IREN 26.9186 5.85% | AIOK 13.609 48.57% | KORU 11.8 8.36% | STLA 4.135 1.35% | BRAI 3.6 69.81% | AAL 12.47 2.21% | TSLA 405.38 3.51% | XP 16.385 4.33% | SDEV 1.065 14.52% | NOK 8.835 2.66% | CLRO 5.8496 17.70% | RWM 14.365 -0.93% | VALE 11.8495 -1.25% | ONDS 6.6294 7.62% | META 624.58 -0.95% | SQQQ 37.116 -3.29% | QID 13.9101 -2.18% | PLUG 1.4228 3.85% | BA 170.9 -9.25% | RBNE 0.1541 -9.35% | CIFR 8.22 6.61% | ITUB 7.815 1.49% | GRAB 2.715 0.18% | MARA 7.0895 3.65%
BIBioCorRx Inc. logo

BioCorRx Inc. (BICX)

Other OTC · Currency in USD
$0.21 ▲ +0.00 (+0.00%)
As of Oct 26, 4:00 PM ET. Market open.

Summary

Previous Close
$0.21
Open
$0.25
Day's Range
$0.21 – $0.25
52 Week Range
$0.15 – $1.28
Volume
5,000
Avg. Volume
5,355
Market Cap
$6.28M
Beta (5Y Monthly)
0.21
PE Ratio (TTM)
--
EPS (TTM)
-$0.11
Earnings Date
Nov 17, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: BioCorRx Inc.

Sector
Healthcare
Industry
Medical - Care Facilities
Full-time employees
3
CEO
Lourdes Felix

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery.

Earnings

Next report: Tue, Nov 17, 2026
EPS estimate -$0.05 · Revenue est. $250.00K
DateEst.Actual
Aug 14, 2026-$0.05-$0.03Beat
May 15, 2026-$0.06-$0.03Beat
Mar 31, 2026-$0.06$0.05Beat
Nov 14, 2025-$0.06-$0.11Miss
Aug 14, 2025–-$0.07
May 15, 2025–-$0.06

Get free alerts on BICX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.